Alprazolam and Emgality drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alprazolam (alprazolam) and Emgality (galcanezumab-gnlm). Common drug interactions include balance disorder among females and adverse reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Alprazolam and Emgality. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

On Jul, 16, 2026

96 people who take Alprazolam and Emgality together, and have interactions are studied.

Alprazolam and Emgality drug interactions.

What are the common drug interactions of Alprazolam and Emgality, by gender? *:

female:

Balance disorder
Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
Blood calcium decreased
Blood cholesterol increased
Sinusitis (inflammation of sinus)
Diarrhoea
Arthralgia (joint pain)
Constipation
Pain
Pain in extremity

male:

Adverse reaction
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Lymphadenopathy (disease or enlargement of lymph nodes)
Malaise (a feeling of general discomfort or uneasiness)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Pulmonary hypertension (increase in blood pressure in the lung artery)
Pyrexia (fever)
Rib fracture

What are the common drug interactions of Alprazolam and Emgality, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chest pain
Drug hypersensitivity
Face oedema (swelling of face)
Rash
Skin exfoliation (removal of the oldest dead skin cells)
Swelling face

30-39:

Contusion (a type of hematoma of tissue in which capillaries)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Loss of consciousness
Rash pruritic (redness with itching)
Pruritus (severe itching of the skin)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Aura
Colitis ulcerative (inflammation of colon with ulcer)
Gallbladder disorder
Gastritis (inflammation of stomach)

40-49:

Psoriasis (immune-mediated disease that affects the skin)
Pyrexia (fever)
Rib fracture
Sinusitis (inflammation of sinus)
Type 2 diabetes mellitus
Vertigo
Chronic kidney disease
Pruritus (severe itching of the skin)
Headache (pain in head)
Insomnia (sleeplessness)

50-59:

Chronic kidney disease
Rash
Asthenia (weakness)
Balance disorder
Death
Dizziness
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hypoaesthesia (reduced sense of touch or sensation)
Infection
Injection site pain

60+:

Constipation
Diarrhoea
Herpes zoster
Pain in extremity
Rash erythematous (redness of the skin)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
Brain injury
Cardiac disorder

What are the existing conditions these people have? *

Migraine (headache): 26 people, 27.08%
Asthma: 11 people, 11.46%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 10.42%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 9.38%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 8.33%
Immunodeficiency Common Variable: 8 people, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 7.29%
Pain: 7 people, 7.29%
Insomnia (sleeplessness): 7 people, 7.29%
Nausea (feeling of having an urge to vomit): 6 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and Emgality?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously